analiza aiqbench

Compal's CGA-QX Docking platform demonstrates a 3,500-fold speedup in molecular docking by hybridizing 30-qubit quantum optimization with GPU-accelerated simulated annealing. This architecture specifically targets binding-energy prediction accuracy for complex targets like Alzheimer's, offering a practical blueprint for integrating quantum workflows into large-scale virtual screening pipelines. The initiative marks a shift from infrastructure provision to active research collaboration, leveraging academic partnerships to refine drug discovery efficiency.